D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 89 Citations 29,069 414 World Ranking 6253 National Ranking 289


What is she best known for?

The fields of study she is best known for:

  • Gene
  • Cancer
  • Internal medicine

Her primary areas of study are Myeloid leukemia, Leukemia, Cancer research, Internal medicine and Oncology. Her Myeloid leukemia research integrates issues from Karyotype, Bioinformatics, Immunophenotyping, Cytogenetics and Bone marrow. Her Leukemia research includes elements of Myeloid, Gene, Chromosomal translocation and Neuroblastoma RAS viral oncogene homolog.

Her Cancer research research is multidisciplinary, incorporating elements of Mutation, Fms-Like Tyrosine Kinase 3, Gene expression profiling, Molecular biology and NPM1. Her work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Pathology. Her Oncology study combines topics from a wide range of disciplines, such as Proportional hazards model, Immunology and Transplantation.

Her most cited work include:

  • Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. (870 citations)
  • Dominant-negative mutations of CEBPA , encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia (775 citations)
  • BRAF mutations in hairy-cell leukemia (749 citations)

What are the main themes of her work throughout her whole career to date?

Susanne Schnittger mainly investigates Leukemia, Internal medicine, Myeloid leukemia, Oncology and Immunology. Her work deals with themes such as Myeloid, Molecular biology, NPM1 and Cytogenetics, which intersect with Leukemia. Her research investigates the connection between Cytogenetics and topics such as Fluorescence in situ hybridization that intersect with issues in Chronic lymphocytic leukemia.

Her Internal medicine research incorporates elements of Gastroenterology, Karyotype and Pathology. Her Myeloid leukemia study results in a more complete grasp of Cancer research. Her Oncology study incorporates themes from Transplantation, Bioinformatics, Proportional hazards model, Imatinib and Cohort.

She most often published in these fields:

  • Leukemia (48.67%)
  • Internal medicine (44.99%)
  • Myeloid leukemia (37.91%)

What were the highlights of her more recent work (between 2014-2020)?

  • Internal medicine (44.99%)
  • Leukemia (48.67%)
  • Oncology (29.79%)

In recent papers she was focusing on the following fields of study:

Susanne Schnittger mainly investigates Internal medicine, Leukemia, Oncology, Immunology and Myeloid leukemia. Her Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Karyotype. The Leukemia study combines topics in areas such as Myeloid, KRAS, NPM1, Cytogenetics and ETV6.

The concepts of her Oncology study are interwoven with issues in Trisomy, Gene mutation, Neuroblastoma RAS viral oncogene homolog, Chromosome abnormality and Acute leukemia. She combines subjects such as Young adult, Survival rate and Somatic evolution in cancer with her study of Immunology. She interconnects Gene duplication, Fms-Like Tyrosine Kinase 3 and Philadelphia chromosome in the investigation of issues within Myeloid leukemia.

Between 2014 and 2020, her most popular works were:

  • Genetic variation at MECOM , TERT , JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms (105 citations)
  • Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V + advanced systemic mastocytosis (95 citations)
  • Molecular diagnostics of myeloproliferative neoplasms (56 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Mutation

Susanne Schnittger mostly deals with Internal medicine, Mutation, Myeloid leukemia, Genetics and Myeloid. Her Internal medicine study combines topics in areas such as Oncology and RUNX1. Her research in Mutation intersects with topics in Molecular biology and NPM1.

Her Myeloid leukemia study improves the overall literature in Immunology. Her research integrates issues of Essential thrombocythemia, Polycythemia vera and Disease in her study of Genetics. Myeloid is a subfield of Cancer research that she tackles.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease.

Susanne Schnittger;Claudia Schoch;Martin Dugas;Wolfgang Kern.
Blood (2002)

1367 Citations

Dominant-negative mutations of CEBPA , encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia

Thomas Pabst;Beatrice U. Mueller;Pu Zhang;Hanna S. Radomska.
Nature Genetics (2001)

1039 Citations

BRAF mutations in hairy-cell leukemia

Enrico Tiacci;Vladimir Trifonov;Gianluca Schiavoni;Antony Holmes.
The New England Journal of Medicine (2011)

1010 Citations

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype

Susanne Schnittger;Claudia Schoch;Wolfgang Kern;Cristina Mecucci.
Blood (2005)

847 Citations

Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin

Ramiro Garzon;Michela Garofalo;Maria Paola Martelli;Roger Briesewitz.
Proceedings of the National Academy of Sciences of the United States of America (2008)

572 Citations

Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized WT1 Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study

Daniel Cilloni;Aline Renneville;Fabienne Hermitte;Robert Kerrin Hills.
Journal of Clinical Oncology (2009)

494 Citations

KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival

Susanne Schnittger;Tobias M. Kohl;Torsten Haferlach;Wolfgang Kern.
Blood (2006)

486 Citations

Landscape Of Genetic Lesions In 944 Patients With Myelodysplastic Syndromes

Yasunobu Nagata;Vera Grossmann;Yusuke Okuno;Ulrike Bacher.
Blood (2013)

476 Citations

Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML).

B. Hanfstein;M. C. Müller;R. Hehlmann;P. Erben.
Leukemia (2012)

444 Citations

New insights to the MLL recombinome of acute leukemias

C. Meyer;E. Kowarz;J. Hofmann;A. Renneville.
Leukemia (2009)

441 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Susanne Schnittger

Hagop M. Kantarjian

Hagop M. Kantarjian

The University of Texas MD Anderson Cancer Center

Publications: 201

Jorge E. Cortes

Jorge E. Cortes

Augusta University

Publications: 153

Torsten Haferlach

Torsten Haferlach

MLL Munich Leukemia Laboratory

Publications: 130

Andreas Hochhaus

Andreas Hochhaus

Friedrich Schiller University Jena

Publications: 129

Claudia Haferlach

Claudia Haferlach

Ludwig-Maximilians-Universität München

Publications: 123

Wolfgang Kern

Wolfgang Kern

Munich Leukemia Laboratory (Germany)

Publications: 121

Farhad Ravandi

Farhad Ravandi

The University of Texas MD Anderson Cancer Center

Publications: 120

Nicholas C.P. Cross

Nicholas C.P. Cross

University of Southampton

Publications: 118

Peter Valent

Peter Valent

Medical University of Vienna

Publications: 112

Rolf Marschalek

Rolf Marschalek

Goethe University Frankfurt

Publications: 108

L. Jeffrey Medeiros

L. Jeffrey Medeiros

The University of Texas MD Anderson Cancer Center

Publications: 106

Wolfgang Hiddemann

Wolfgang Hiddemann

Ludwig-Maximilians-Universität München

Publications: 101

Daniel G. Tenen

Daniel G. Tenen

National University of Singapore

Publications: 100

Hartmut Döhner

Hartmut Döhner

University of Ulm

Publications: 99

Ayalew Tefferi

Ayalew Tefferi

Mayo Clinic

Publications: 93

Clara D. Bloomfield

Clara D. Bloomfield

The Ohio State University

Publications: 88

Something went wrong. Please try again later.